|
|
|
Insider
Information: |
Ricks David A |
Relationship: |
Director |
City: |
Indianapolis |
State: |
IN |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
481,225 |
|
Indirect Shares
|
144,309 |
|
|
Direct
Value |
$399,904,288 |
|
|
Indirect Value
|
$118,355,154 |
|
|
Total
Shares |
625,534 |
|
|
Total
Value |
$518,259,443 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
Percentage
Gain/Loss : |
75.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Eli Lilly & Co |
LLY |
President, Chair, and ... |
2024-02-12 |
479,250 |
2024-02-12 |
139,637 |
Premium* |
|
Adobe Systems Inc |
ADBE |
Director |
2024-04-17 |
1,975 |
2024-04-17 |
4,672 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-02-02 |
4 |
AS |
$71.51 |
$341,031 |
D/D |
(4,769) |
63,285 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-02-01 |
4 |
D |
$79.10 |
$368,290 |
D/D |
(4,656) |
85,136 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-02-01 |
4 |
D |
$77.03 |
$372,594 |
D/D |
(4,837) |
104,563 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-02-01 |
4 |
D |
$72.00 |
$427,680 |
D/D |
(5,940) |
68,054 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2019-10-25 |
4 |
B |
$108.38 |
$500,174 |
D/D |
4,615 |
157,405 |
2.81 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2014-01-28 |
4 |
A |
$54.23 |
$560,847 |
D/D |
10,342 |
37,170 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2013-01-25 |
4 |
A |
$53.21 |
$594,569 |
D/D |
11,174 |
29,941 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2019-02-01 |
4 |
D |
$119.86 |
$657,432 |
D/D |
(5,485) |
126,223 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-02-01 |
4 |
D |
$81.45 |
$778,581 |
D/D |
(9,559) |
131,250 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2018-01-29 |
4 |
A |
$87.60 |
$1,086,853 |
D/D |
12,407 |
119,483 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2017-01-27 |
4 |
A |
$75.38 |
$1,521,395 |
D/D |
20,183 |
99,156 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2016-01-26 |
4 |
A |
$81.96 |
$1,558,551 |
D/D |
19,016 |
79,949 |
0 |
- |
|
LLY |
Eli Lilly & Co |
SVP and Pres, Lilly Bio-Meds |
|
2015-01-28 |
4 |
A |
$70.97 |
$1,933,791 |
D/D |
27,248 |
61,403 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2019-02-04 |
4 |
A |
$120.17 |
$3,192,556 |
D/D |
26,567 |
152,790 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2020-02-01 |
4 |
D |
$139.64 |
$4,341,268 |
D/D |
(31,089) |
195,666 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2022-02-01 |
4 |
D |
$245.39 |
$6,176,466 |
D/D |
(25,170) |
399,779 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2021-02-01 |
4 |
D |
$207.97 |
$7,016,492 |
D/D |
(33,738) |
309,901 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Chair, and CEO |
|
2023-02-01 |
4 |
D |
$344.15 |
$7,350,700 |
D/D |
(21,359) |
391,743 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Chair, and CEO |
|
2024-02-01 |
4 |
D |
$645.61 |
$8,547,876 |
D/D |
(13,240) |
441,814 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2020-02-11 |
4 |
A |
$144.25 |
$11,191,781 |
D/D |
77,586 |
268,252 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2022-02-09 |
4 |
A |
$243.27 |
$16,543,333 |
D/D |
68,004 |
467,783 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Chair, and CEO |
|
2023-02-10 |
4 |
A |
$345.12 |
$19,398,505 |
D/D |
56,208 |
443,751 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President & CEO |
|
2021-02-08 |
4 |
A |
$205.77 |
$26,820,679 |
D/D |
130,343 |
440,244 |
0 |
- |
|
LLY |
Eli Lilly & Co |
President, Chair, and CEO |
|
2024-02-12 |
4 |
A |
$737.26 |
$28,304,886 |
D/D |
38,392 |
479,250 |
0 |
- |
|
74 Records found
|
|
Page 3 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|